Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AXL | P30530 | 14/20 | 0.75 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.47 |
| ▸ | MRGPRX1 | Q96LB2 | 2/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | MET | P08581 | 1/20 | 0.45 |
| ▸ | SRC | P12931 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10318681 | 0.93 | AXL (0.64) | AXLSLC40A1MRGPRX1ALDH1A1MAPT | |
| SCHEMBL10316949 | 0.92 | AXL (0.63) | AXLSLC40A1MRGPRX1EGFRMET | |
| SCHEMBL10317039 | 0.90 | AXL (0.63) | AXLMRGPRX1ALDH1A1MAPTSCN9A | |
| SCHEMBL10316977 | 0.89 | AXL (0.75) | AXL | |
| SCHEMBL10318293 | 0.88 | AXL (0.73) | AXLMRGPRX1ALDH1A1MAPT | |
| SCHEMBL10317984 | 0.87 | AXL (0.56) | AXLSLC40A1MRGPRX1EGFRMET | |
| SCHEMBL10319281 | 0.87 | AXL (0.73) | AXL | |
| SCHEMBL1592063 | 0.86 | AXL (1.00) | AXLEGFRMETSRC | |
| SCHEMBL10319493 | 0.86 | AXL (0.60) | AXLSLC40A1MRGPRX1ALDH1A1MAPT | |
| SCHEMBL10317131 | 0.85 | AXL (0.73) | AXLSCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2262772-B1 | QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS | MAX PLANCK GESELLSCHAFT (DE) | 2012-07-18 | — | — | EP | claimed |